These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1955097)

  • 1. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
    Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
    Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
    Heaton DA; Lazarus NR; Pyke DA; Leslie RD
    Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.
    Chaillous L; Rohmer V; Maugendre D; Lecomte P; Maréchaud R; Marre M; Guilhem I; Charbonnel B; Saï P
    Metabolism; 1996 Mar; 45(3):306-14. PubMed ID: 8606636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.
    Palmer JP; Benson JW; Walter RM; Ensinck JW
    J Clin Invest; 1976 Sep; 58(3):565-70. PubMed ID: 783201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
    Vardi P; Crisa L; Jackson RA
    Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute insulin response to glucose and glucagon in subjects at risk of developing type I diabetes.
    Vialettes B; Zevaco-Mattei C; Thirion X; Lassmann-Vague V; Pieron H; Mercier P; Vague P
    Diabetes Care; 1993 Jul; 16(7):973-7. PubMed ID: 8359105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 years.
    Bardet S; Rohmer V; Maugendre D; Valentin A; Gallois Y; Stetieh H; Marre M; Allannic H; Charbonnel B; Sai P
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1310-7. PubMed ID: 2146283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.
    Ganda OP; Srikanta S; Brink SJ; Morris MA; Gleason RE; Soeldner JS; Eisenbarth GS
    Diabetes; 1984 Jun; 33(6):516-21. PubMed ID: 6373458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet cell surface antibodies preferentially inhibit glucose-stimulated insulin release in vitro.
    Kitagawa Y; Kanatsuna T; Kajiyama S; Nakamura N; Nakamura Y; Kano Y; Nakano K; Kondo M; Ludvigsson J
    Diabetes Res Clin Pract; 1990 Apr; 9(1):7-13. PubMed ID: 2190782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered islet beta-cell function before the onset of type 1 (insulin-dependent) diabetes mellitus.
    Lo SS; Hawa M; Beer SF; Pyke DA; Leslie RD
    Diabetologia; 1992 Mar; 35(3):277-82. PubMed ID: 1563585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
    Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
    Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and insulin secretion in potential diabetes.
    Tiengo A; Fedele D; Muggeo M; Nosadini R; Molinari M; Garotti MC; Crepaldi G
    Acta Diabetol Lat; 1978; 15(3-4):143-51. PubMed ID: 360748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.